Social networks
1,100 561Activities
Entity types
Location
David Goldberg Centre for Health Services Research, 16 De Crespigny Park, London SE5 8AF, UK
London
United Kingdom
Employees
Scale: 51-200
Estimated: 3
Engaged corporates
8Added in Motherbase
4 years, 10 months agoA collaborative research project exploring the potential of wearable devices to help prevent & treat MDD, MS & epilepsy
Remote Assessment of Disease and Relapse – Central Nervous System (RADAR-CNS) is an international research programme exploring the potential of wearable devices to help prevent and treat depression, multiple sclerosis and epilepsy.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115902. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. See www.imi.europa.eu for more details.
Wearable technology, Depression, Multiple Sclerosis (MS), Epilepsy, and research
Project examining the potential of smartphones and wearable devices to manage and treat brain disorders like multiple sclerosis (MS), epilepsy, and depression.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
UK Atomic Energy Authority Research, National and local authorities | UK Atomic Energy Authority Research, National and local authorities | Other 30 Sep 2023 | | |
Elsevier Publishing, IT Services and IT Consulting | Elsevier Publishing, IT Services and IT Consulting | Other 28 Feb 2023 | | |
UCB Pharmaceutical Manufacturing | UCB Pharmaceutical Manufacturing | Other 7 Oct 2022 30 Sep 2022 | | |
imec Research Services | imec Research Services | Other 7 Oct 2022 30 Sep 2022 | | |
Accenture Consulting, audit, Business Consulting and Services | Accenture Consulting, audit, Business Consulting and Services | Other 28 Mar 2017 | | |
Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Other 26 Sep 2019 | | |
Biogen Biotechnology, Biotechnology Research | Biogen Biotechnology, Biotechnology Research | Other 7 Oct 2022 30 Sep 2022 | | |
Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 10 Oct 2022 | |